Natalie Nairn
![Natalie Nairn Natalie Nairn](https://proteindegradation.com/wp-content/uploads/sites/82/2024/06/Natalie-Nairn-150x150.jpg)
Company: Cyclera Therapeutics
Job title: Cofounder and CEO
Seminars:
CYpHER: Catalytic Extracellular TPD for Potent Durable Effect in Oncology & CNS Disease 9:00 am
Engineering bispecific proteins that utilize transferrin receptor and pH-sensitive target binding to direct disease-driving proteins to the endolysosomal system Catalytic activity provides high potency and durability PD activity across mutational settings with superior activity and targeting versus traditional modalitiesRead more
day: Post-Conference Focus Day